Chase AIBulk Dataset ExportPricingFAQsBlog
Display currency
Loading news…

Chimerix

Durham, North Carolina, United States

Chimerix is a biotechnology company developing therapeutics for antiviral diseases.

Chimerix on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.

Chimerix was acquired by Jazz Pharmaceuticals in 2025 for $935M.
Total Funding
$543.14M
Funding Rounds
14
Last Funding
Acquisitions
1
Monthly Visits
Contacts
102

About Chimerix

Funding & Financials

Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

Web Traffic

Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Company Info

Org types
company
HQ
Durham, North Carolina, United States

Chimerix Funding Rounds

14 results
Upgrade to Pro to view this datasetUpgrade
Organization NameFunding TypeLead Investor NamesOrg Hq Country
1–5 of 14Show
Page 1 / 3

Chimerix Acquisitions

1 results
Acquiree NameAcquirer NameAcquiree IndustriesAcquiree Hq Country
Oncoceutics$78M2021-01-08ChimerixBiotechnologyClinical TrialsHealth CareMedicalPharmaceuticalUnited States
1–1 of 1Show
Page 1 / 1

Chimerix Key People

Chairman of the Board of Directors
Chief Financial Officer
Chief Science Officer
Vice President Regulatory Affairs
102
professional contacts at Chimerix
Contact execs at Chimerix

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions
Bulk Dataset Export

Need the data in bulk? Buy the entire dataset.

5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools

Delivered as CSV, JSON or Parquet — at startup-friendly pricing.

See bulk export

FAQs about Chimerix

People who checked this page also checked these

Browse the full Acquirezy directory.